Washington State House of Representatives Office of Program Research | BILL ANALYSIS |
Health Care & Wellness Committee |
SSB 6663
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent. |
Brief Description: Concerning dual diagnoses of eating disorder and diabetes mellitus type 1.
Sponsors: Senate Committee on Ways & Means (originally sponsored by Senators Brown, Becker and Walsh).
Brief Summary of Substitute Bill |
|
Hearing Date: 2/25/20
Staff: Nico Wedekind (786-7290) and Jim Morishima (786-7191).
Background:
"Diabulimia" is an eating disorder typically associated with individuals with type 1 diabetes in which the individual purposefully restricts insulin in order to lose weight. Diabulimia does not have a separate diagnostic code in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5), but the DSM-5 classifies insulin omission as a purging behavior. Some medical professionals have used the term ED-DMT1 (Eating Disorder-Diabetes Mellitus Type 1) to describe the disorder, as this term is used to refer to any type of eating disorder comorbid with type 1 diabetes.
Long term consequences of diabulimia can include kidney, liver, or heart disease.
Summary of Bill:
By December 1, 2020, the Department of Health's website must include links to existing information on diabulimia.
Appropriation: None.
Fiscal Note: Available. New fiscal note requested on February 21, 2020.
Effective Date: The bill takes effect 90 days after adjournment of the session in which the bill is passed.